- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, November 27, 2019
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A study published in the December 2012 issue of The American Journal of Managed Care® (AJMC®) spoke of the importance of emotional and practical support in promoting medical adherence. The study, “Association Between Different Types of Social Support and Medication Adherence,” was highlighted in an article by Stabroek News.
A blog post on drug pricing in Health Affairs highlighted 4 articles from AJMC®’s sister site The Center for Biosimilars®. The articles referenced included the following: “Amgen and Allergan Launch Mvasi and Kanjinti, the First Anticancer Biosimilars, in the United States,” “Mylan Confirms That It Has Launched Fulphila in the United States,” “Apobiologix Launches Pegfilgrastim Biosimilar in Canada,” and “Mundipharma Launches Biosimilar Pegfilgrastim in Germany, the Netherlands, and Ireland.”
An article appearing in Newsweek detailed the passage of the Workplace Violence Prevention for Healthcare and Social Service Workers Act in the US House of Representatives last Friday. The article referenced a 2019 AJMC® newsroom article titled “Violence Against Healthcare Workers: A Rising Epidemic,” which stressed that more attention is warranted to increasing rates of violence against employees in the field of healthcare.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More
